Beyond Air, Inc. (XAIR) fundamentals score
Beyond Air operates in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management
Surgical & Medical Instruments & Apparatus · Healthcare · Listed on NASDAQ
Overall: 5.2 out of 10, Mixed fundamentals
- Growth: 5.0/10
- Profitability: 3.4/10
- Financial health: 4.8/10
- Earnings quality: 7.0/10
- Valuation: 7.0/10
Scores are calculated from Beyond Air, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10